ChemRar , an R&D institute and resident at the Skolkovo Foundation Biomedical Technologies Cluster, has created a platform to develop innovative drugs against Covid-19. The platform is now available to potential partners and the company is inviting international...
The company, Kromis , a resident of the biomedical technologies cluster of the Skolkovo Foundation, received a product license from the Ministry of Health of the Russian Federation for the antiviral medication “Avifavir.” Avifavir (the active...